Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2024-02-29 to 2024-03-01
Current total value of award: $1339.17
Description: 4563862624!ORALAIR 300 IR SUBLINGUAL TAB 30S